Cargando…
Vaccine Effectiveness against SARS-CoV-2 Variants in Adolescents from 15 to 90 Days after Second Dose: A Population-Based Test-Negative Case-Control Study
OBJECTIVE: The objective of this study was to estimate the vaccine effectiveness (VE) against hospitalization and severe illness in adolescents due to infection with SARS-CoV-2 variants (gamma, delta, and omicron). STUDY DESIGN: A test-negative, case-control analysis was conducted in Brazil from Jul...
Autores principales: | Oliveira, Eduardo A., Oliveira, Maria Christina L., Colosimo, Enrico A., Simões e Silva, Ana Cristina, Mak, Robert H., Vasconcelos, Mariana A., Silva, Ludmila R., Martelli, Daniella B., Pinhati, Clara C., Martelli-Júnior, Hercílio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519371/ https://www.ncbi.nlm.nih.gov/pubmed/36181868 http://dx.doi.org/10.1016/j.jpeds.2022.09.039 |
Ejemplares similares
-
Comparison of the First and Second Waves of the Coronavirus Disease 2019 Pandemic in Children and Adolescents in a Middle-Income Country: Clinical Impact Associated with Severe Acute Respiratory Syndrome Coronavirus 2 Gamma Lineage
por: Oliveira, Eduardo A., et al.
Publicado: (2022) -
Effectiveness of BNT162b2 and CoronaVac vaccines against omicron in children aged 5 to 11 years
por: Oliveira, Eduardo A., et al.
Publicado: (2023) -
Outcomes and risk factors for death among hospitalized children and adolescents with kidney diseases and COVID-19: an analysis of a nationwide database
por: Vasconcelos, Mariana A., et al.
Publicado: (2022) -
Risk factors for COVID-19 mortality in hospitalised children and adolescents in Brazil – Authors' reply
por: Oliveira, Eduardo A, et al.
Publicado: (2021) -
Clinical characteristics and risk factors for death among hospitalised children and adolescents with COVID-19 in Brazil: an analysis of a nationwide database
por: Oliveira, Eduardo A, et al.
Publicado: (2021)